These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1480022)

  • 21. Plasminogen activation by invasive human pathogens.
    Boyle MD; Lottenberg R
    Thromb Haemost; 1997 Jan; 77(1):1-10. PubMed ID: 9031440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
    Shen GX
    Int J Mol Med; 1998 Feb; 1(2):399-408. PubMed ID: 9852242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The plasminogen activator/plasmin system.
    Vassalli JD; Sappino AP; Belin D
    J Clin Invest; 1991 Oct; 88(4):1067-72. PubMed ID: 1833420
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth factors in the regulation of plasminogen-plasmin system in tumor cells.
    Keski-Oja J; Koli K; Lohi J; Laiho M
    Semin Thromb Hemost; 1991 Jul; 17(3):231-9. PubMed ID: 1839081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression.
    DeClerck YA; Laug WE
    Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel assay to evaluate promoting effects of proteins on calcium oxalate crystal invasion through extracellular matrix based on plasminogen/plasmin activity.
    Chiangjong W; Thongboonkerd V
    Talanta; 2012 Nov; 101():240-5. PubMed ID: 23158318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix.
    Lähteenmäki K; Virkola R; Pouttu R; Kuusela P; Kukkonen M; Korhonen TK
    Infect Immun; 1995 Sep; 63(9):3659-64. PubMed ID: 7642304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth].
    Cosić SJ; Kovac Z
    Lijec Vjesn; 2011; 133(1-2):56-63. PubMed ID: 21644280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PA-plasmin system during murine embryogenesis.
    Sappino AP; Wohlwend A; Huarte J; Belin D; Vassalli JD
    Ann N Y Acad Sci; 1992 Dec; 667():41. PubMed ID: 1309061
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasminogen and plasminogen activator assembly on the human endothelial cell.
    Shih GC; Hajjar KA
    Proc Soc Exp Biol Med; 1993 Mar; 202(3):258-64. PubMed ID: 8437979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of plasminogen activator-plasmin system in tumor angiogenesis.
    Rakic JM; Maillard C; Jost M; Bajou K; Masson V; Devy L; Lambert V; Foidart JM; Noël A
    Cell Mol Life Sci; 2003 Mar; 60(3):463-73. PubMed ID: 12737307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an extracellular plasmin-dependent proteolytic system in mineralizing matrices.
    Robinson RM; Taylor RE; Birkedal-Hansen H
    Calcif Tissue Int; 1984 Jan; 36(1):31-8. PubMed ID: 6231085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen-dependent proteolytic activity in Bifidobacterium lactis.
    Candela M; Miccoli G; Bergmann S; Turroni S; Vitali B; Hammerschmidt S; Brigidi P
    Microbiology (Reading); 2008 Aug; 154(Pt 8):2457-2462. PubMed ID: 18667578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix.
    Tzarfaty-Majar V; López-Alemany R; Feinstein Y; Gombau L; Goldshmidt O; Soriano E; Muñoz-Cánoves P; Klar A
    J Biol Chem; 2001 Jul; 276(30):28233-41. PubMed ID: 11359777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator and protease inhibitor activities in isolated rat thymocytes.
    Mayer M; Finci Z; Kanaany J; Kaiser N
    Mol Cell Biochem; 1985 Mar; 66(2):137-44. PubMed ID: 3157048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolytic pathways and the endothelium.
    Hekman CM; Loskutoff DJ
    Semin Thromb Hemost; 1987 Oct; 13(4):514-27. PubMed ID: 2827312
    [No Abstract]   [Full Text] [Related]  

  • 39. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues.
    ASTRUP T; ALBRECHTSEN OK
    Scand J Clin Lab Invest; 1957; 9(3):233-43. PubMed ID: 13495339
    [No Abstract]   [Full Text] [Related]  

  • 40. The content of plasminogen activator in the human urinary tract.
    LADEHOFF AA
    Scand J Clin Lab Invest; 1960; 12():136-9. PubMed ID: 14413370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.